|
NIF3L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.018990E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.847000E-04 |
| Normal-vs-Stage2 |
7.390700E-04 |
| Normal-vs-Stage3 |
2.842800E-04 |
| Normal-vs-Stage4 |
2.46749999999185E-05 |
| Stage1-vs-Stage2 |
2.095200E-01 |
| Stage1-vs-Stage3 |
2.795800E-01 |
| Stage1-vs-Stage4 |
1.073610E-01 |
| Stage2-vs-Stage3 |
6.939600E-01 |
| Stage2-vs-Stage4 |
8.418800E-01 |
| Stage3-vs-Stage4 |
4.998200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.786120E-04 |
| Normal-vs-AfricanAmerican |
2.182100E-02 |
| Normal-vs-Asian |
7.622200E-02 |
| Caucasian-vs-AfricanAmerican |
7.455800E-01 |
| Caucasian-vs-Asian |
1.358770E-01 |
| AfricanAmerican-vs-Asian |
4.599200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.240520E-04 |
| Normal-vs-Female |
2.420100E-04 |
| Male-vs-Female |
6.441400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.976600E-04 |
| Normal-vs-Age(41-60Yrs) |
6.389500E-04 |
| Normal-vs-Age(61-80Yrs) |
8.19020000000226E-05 |
| Normal-vs-Age(81-100Yrs) |
1.281830E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.042600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.457800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.386800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.814200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.088800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.118400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.918440E-01 |
| Classical-VS-Follicular |
4.241500E-02 |
| Classical-VS-Other |
1.687190E-01 |
| Classical-VS-Normal |
5.841900E-04 |
| Tall-VS-Follicular |
1.550260E-02 |
| Tall-VS-Other |
7.925500E-02 |
| Tall-VS-Normal |
2.225000E-01 |
| Follicular-VS-Other |
7.043200E-01 |
| Follicular-VS-Normal |
4.42310000000612E-05 |
| Other-VS-Normal |
1.244250E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.754710E-04 |
| Normal-vs-N1 |
4.36329999999874E-05 |
| N0-vs-N1 |
2.131000E-01 |
|
|
